Minocycline alleviates beta-amyloid protein and tau pathology via restraining neuroinflammation induced by diabetic metabolic disorder

References

• WangKCWoungLCTsaiMTLiuCCSuYHLiCYRisk of Alzheimer’s disease in relation to diabetes: a population-based cohort studyNeuroepidemiology20123823724422572745
   PubMed Web of Science ®Google Scholar
• TakedaS[Pathological interaction between diabetes mellitus and Alzheimer’s disease.]Nihon Shinkei Seishin Yakurigaku Zasshi201232239244 Japanese23373309
   PubMedGoogle Scholar
• KimBBackusCOhSFeldmanELhyperglycemia-induced tau cleavage in vitro and in vivo: a possible link between diabetes and Alzheimer’s diseaseJ Alzheimers Dis20133472773923254634
   PubMed Web of Science ®Google Scholar
• BartlJMonoranuCMWagnerAKKolterJRiedererPGrunblattEAlzheimer’s disease and type 2 diabetes: two diseases, one common link?World J Biol Psychiatry20131423324022332892
   PubMed Web of Science ®Google Scholar
• PilcherHAlzheimer’s disease could be “type 3 diabetes”Lancet Neurol2006538838916639835
   PubMed Web of Science ®Google Scholar
• de la MonteSMTongMLester-CollNPlaterMJrWandsJRTherapeutic rescue of neurodegeneration in experimental type 3 diabetes: relevance to Alzheimer’s diseaseJ Alzheimers Dis2006108910916988486
   PubMed Web of Science ®Google Scholar
• ZhangZYZhangZFauserUSchluesenerHJImproved outcome of EAN, an animal model of GBS, through amelioration of peripheral and central inflammation by minocyclineJ Cell Mol Med20091334135118400050
   PubMed Web of Science ®Google Scholar
• KuangXScofieldVLYanMStoicaGLiuNWongPKAttenuation of oxidative stress, inflammation and apoptosis by minocycline prevents retrovirus-induced neurodegeneration in miceBrain Res2009128617418419523933
   PubMed Web of Science ®Google Scholar
• CaiZZhaoYYaoSBin ZhaoBIncreases in beta-amyloid protein in the hippocampus caused by diabetic metabolic disorder are blocked by minocycline through inhibition of NF-kappaB pathway activationPharmacol Rep20116338139121602593
   PubMed Web of Science ®Google Scholar
• CaiZYYanYChenRMinocycline reduces astrocytic reactivation and neuroinflammation in the hippocampus of a vascular cognitive impairment rat modelNeurosci Bull201026283620101270
   PubMed Web of Science ®Google Scholar
• CaiZYYanYSunSQMinocycline attenuates cognitive impairment and restrains oxidative stress in the hippocampus of rats with chronic cerebral hypoperfusionNeurosci Bull20082430531318839024
   PubMedGoogle Scholar
• GranicIDolgaAMNijholtIMvan DijkGEiselULInflammation and NF-kappaB in Alzheimer’s disease and diabetesJ Alzheimers Dis20091680982119387114
   PubMed Web of Science ®Google Scholar
• de la MonteSMBrain insulin resistance and deficiency as therapeutic targets in Alzheimer’s diseaseCurr Alzheimer Res20129356622329651
   PubMed Web of Science ®Google Scholar
• DongSFHongYLiuMBerberine attenuates cardiac dysfunction in hyperglycemic and hypercholesterolemic ratsEur J Pharmacol201166036837421458442
   PubMed Web of Science ®Google Scholar
• ReedMJMeszarosKEntesLJA new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated ratMetabolism2000491390139411092499
   PubMed Web of Science ®Google Scholar
• ClarkJDGebhartGFGonderJCKeelingMEKohnDFSpecial Report: The 1996 Guide for the Care and Use of Laboratory AnimalsILAR J1997381414811528046
   PubMedGoogle Scholar
• RoulstonCLLawrenceAJWiddopREJarrottBMinocycline treatment attenuates microglia activation and non-angiotensin II [125I] CGP42112 binding in brainstem following nodose ganglionectomyNeuroscience20051351241125316165304
   PubMed Web of Science ®Google Scholar
• OzakiKSanoTTsujiNMatsuuraTNaramaIInsulin-induced hypoglycemic peripheral motor neuropathy in spontaneously diabetic WBN/Kob ratsComp Med20106028228720819377
   PubMed Web of Science ®Google Scholar
• TzeWJTaiJWongFCDavisHRStudies with implantable artificial capillary units containing rat islets on diabetic dogsDiabetologia1980195415456780399
   PubMed Web of Science ®Google Scholar
• BhattacharyaPPandeyAKPaulSMinocycline and magnesium in combination may be a good therapeutic intervention for cerebral ischemiaMed Hypotheses2011771129113121985758
   PubMed Web of Science ®Google Scholar
• MartinABoisgardRKassiouMDolleFTavitianBReduced PBR/TSPO expression after minocycline treatment in a rat model of focal cerebral ischemia: a PET study using [(18)F]DPA-714Mol Imaging Biol201113101520383592
   PubMed Web of Science ®Google Scholar
• ChenXMaXJiangYPiRLiuYMaLThe prospects of minocycline in multiple sclerosisJ Neuroimmunol20112351821565409
   PubMed Web of Science ®Google Scholar
• DefauxAZurichMGHoneggerPMonnet-TschudiFMinocycline promotes remyelination in aggregating rat brain cell cultures after interferon-gamma plus lipopolysaccharide-induced demyelinationNeuroscience2011187849221549181
   PubMed Web of Science ®Google Scholar
• ZhangWNarayananMFriedlanderRMAdditive neuroprotective effects of minocycline with creatine in a mouse model of ALSAnn Neurol20035326727012557297
   PubMed Web of Science ®Google Scholar
• GordonPHMooreDHMillerRGEfficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trialLancet Neurol200761045105317980667
   PubMed Web of Science ®Google Scholar
• BlumDChtartoATenenbaumLBrotchiJLevivierMClinical potential of minocycline for neurodegenerative disordersNeurobiol Dis20041735936615571972
   PubMed Web of Science ®Google Scholar
• BantubungiKJacquardCGrecoAMinocycline in phenotypic models of Huntington’s diseaseNeurobiol Dis20051820621715649711
   PubMed Web of Science ®Google Scholar
• YongVWWellsJGiulianiFCashaSPowerCMetzLMThe promise of minocycline in neurologyLancet Neurol2004374475115556807
   PubMed Web of Science ®Google Scholar
• DuYMaZLinSMinocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson’s diseaseProc Natl Acad Sci USA200198146691467411724929
   PubMed Web of Science ®Google Scholar
• AmlienIKFjellAMWalhovdKBMild cognitive impairment: cerebrospinal fluid tau biomarker pathologic levels and longitudinal changes in white matter integrityRadiology201326629530323151827
   PubMed Web of Science ®Google Scholar
• ParnettiLChiasseriniDEusebiPPerformance of abeta1–40, abeta1–42, total tau, and phosphorylated tau as predictors of dementia in a cohort of patients with mild cognitive impairmentJ Alzheimers Dis20122922923822232006
   PubMed Web of Science ®Google Scholar
• LomoioSScheriniENecchiDBeta-amyloid overload does not directly correlate with SAPK/JNK activation and tau protein phosphorylation in the cerebellar cortex of Ts65Dn miceBrain Res2009129719820619703431
   PubMed Web of Science ®Google Scholar
• MohandasERajmohanVRaghunathBNeurobiology of Alzheimer’s diseaseIndian J Psychiatry200951556119742193
   PubMedGoogle Scholar
• PaponMAEl KhouryNBMarcouillerFDeregulation of protein phosphatase 2A and hyperphosphorylation of tau protein following onset of diabetes in NOD miceDiabetes20136260961722961084
   PubMed Web of Science ®Google Scholar
• WangYChengZQinWJiaJVal97 Leu mutant presenilin-1 induces tau hyperphosphorylation and spatial memory deficit in mice and the underlying mechanismsJ Neurochem201212113514521929538
   PubMed Web of Science ®Google Scholar
• AugustinackJCSchneiderAMandelkowEMHymanBTSpecific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer’s diseaseActa Neuropathol2002103263511837744
   PubMed Web of Science ®Google Scholar
• LiuYSuYWangJRapamycin decreases tau phosphorylation at Ser214 through regulation of cAMP-dependent kinaseNeurochem Int20136245846723357480
   PubMed Web of Science ®Google Scholar
• KellerAFGravelMKrizJTreatment with minocycline after disease onset alters astrocyte reactivity and increases microgliosis in SOD1 mutant miceExp Neurol2011228697921168408
   PubMed Web of Science ®Google Scholar
• GiulianiFHaderWYongVWMinocycline attenuates T cell and microglia activity to impair cytokine production in T cell-microglia interactionJ Leukoc Biol20057813514315817702
   PubMed Web of Science ®Google Scholar
• SiQCosenzaMKimMOA novel action of minocycline: inhibition of human immunodeficiency virus type 1 infection in microgliaJ Neurovirol20041028429215385251
   PubMed Web of Science ®Google Scholar
• TikkaTFiebichBLGoldsteinsGKeinanenRKoistinahoJMinocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microgliaJ Neurosci2001212580258811306611
   PubMed Web of Science ®Google Scholar
• YenariMAXuLTangXNQiaoYGiffardRGMicroglia potentiate damage to blood-brain barrier constituents: improvement by minocycline in vivo and in vitroStroke2006371087109316497985
   PubMed Web of Science ®Google Scholar
• ParthsarathyVHolscherCThe type 2 diabetes drug liraglutide reduces chronic inflammation induced by irradiation in the mouse brainEur J Pharmacol2013700425023276669
   PubMed Web of Science ®Google Scholar
• CelikSErdoganSCaffeic acid phenethyl ester (CAPE) protects brain against oxidative stress and inflammation induced by diabetes in ratsMol Cell Biochem2008312394618265948
   PubMed Web of Science ®Google Scholar
• HurleyLLTizabiYNeuroinflammation, neurodegeneration, and depressionNeurotox Res20132313114422895696
   PubMed Web of Science ®Google Scholar
• PintadoCGavilanMPGavilanELipopolysaccharide-induced neuroinflammation leads to the accumulation of ubiquitinated proteins and increases susceptibility to neurodegeneration induced by proteasome inhibition in rat hippocampusJ Neuroinflammation201298722559833
   PubMed Web of Science ®Google Scholar
• CraftJMWattersonDMVan EldikLJHuman amyloid beta-induced neuroinflammation is an early event in neurodegenerationGlia20065348449016369931
   PubMed Web of Science ®Google Scholar
• CaiZZhaoBRatkaAOxidative stress and beta-amyloid protein in Alzheimer’s diseaseNeuromolecular Med20111322325021901428
   PubMed Web of Science ®Google Scholar
• TexelSJMattsonMPImpaired adaptive cellular responses to oxidative stress and the pathogenesis of Alzheimer’s diseaseAntioxid Redox Signal2011141519153420849373
   PubMed Web of Science ®Google Scholar